Alison R. Mercer-Smith

Univ Of North Carolina Chapel Hill

$173,362

Attributed

$173,362

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $51K · FY2019–22

$100K$75K$50K$25K$0

'19

'20

'21

'22

Funding mix

By agency

NIH$173,362 · 1

By mechanism

F30$173,362 · 1

Top collaborators

No co-investigators on record.

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Combined Modality Therapy”

Barbara Burtness · Yale University$11,235,253
Jurgen Bernd Bulitta · State University Of New York At Buffalo$7,090,719
Kathleen N. Moore · University Of Oklahoma$6,686,608
Nilu Goonetilleke · Univ Of North Carolina Chapel Hill$6,073,977
Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru$5,834,007
Nader Fotouhi · Global Alliance For Tb Drug Development$5,472,466

Research focus

Combined Modality TherapyAftercareAdjuvant TherapyAdjuvantAreaAutologousAutopsyAllogenicApoptosisBioluminescence ImagingBrainBrain NeoplasmsCancer CellCell LineCellsCessation Of LifeChemokineBasic ScienceBedsClinicCoculture TechniquesCombatCombinatorialCranial Irradiation

Grant awards (4)

Therapeutic Engineered Stem Cells as a New Adjuvant Therapy for Non-Small Cell Lung Cancer Brain Metastases$48,776

F30 · FY2022 · CA · contact PI

Therapeutic Engineered Stem Cells as a New Adjuvant Therapy for Non-Small Cell Lung Cancer Brain Metastases$51,036

F30 · FY2021 · CA · contact PI

Therapeutic Engineered Stem Cells as a New Adjuvant Therapy for Non-Small Cell Lung Cancer Brain Metastases$37,027

F30 · FY2020 · CA · contact PI

Therapeutic Engineered Stem Cells as a New Adjuvant Therapy for Non-Small Cell Lung Cancer Brain Metastases$36,523

F30 · FY2019 · CA · contact PI